Greenville Health System, Institute for Translational Oncology Research is a clinical research site located in Greenville, South Carolina, United States 29605.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
Greenville Health System, Institute for Translational Oncology Research has participated in 5 clinical trials.
Therapeutic areas: Pancreatic Cancer, Non-small Cell Lung Cancer, Esophagogastric Cancer.
Sponsors: Gilead Sciences, Aptevo Research and Development LLC, Taiho Oncology, Inc..
Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Greenville Health System, Institute for Translational Oncology Research has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Greenville Health System, Institute for Translational Oncology Research has 5 clinical trials on record. Their work covers Pancreatic Cancer, Non-small Cell Lung Cancer, Esophagogastric Cancer.
Yes — Greenville Health System, Institute for Translational Oncology Research holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.